X-spine Launches Axograft™ Biologics Portfolio

Spinal products company X-spine Systems, Inc., has added a broad line of biologics to its product portfolio. The initial launch of biologics includes Axograft™ DBM Putty, Axograft™ Cancellous Crushed Allograft, Axograft™ Crunch Allograft and Axograft™ Amniotic Membrane.


October 20th through 22nd sees the annual holding of the Congress of Neurological Surgeons Annual Meeting in Boston, MA, and event at which X-spine Systems is unveiling its biologics products. The Axograft biological line will complement X-spine’s comprehensive line of spinal fixation products. The Axograft products will be used to promote spinal fusion, bone healing and wound treatment in spinal arthrodesis procedures.

Axograft joins X-spine’s growing portfolio of spinal implant products, which includes the Spider Cervical™ Plating System, Silex™ Sacroiliac Fusion system, Irix-C™ Cervical Integrated Fusion System, Xpress Minimally Invasive Pedicle Screw System, Zyfix™ Facet Fusion System, Axle™ and Axle-X™ Interspinous Fusion Systems, X90™ Pedicle Screw System, Fortex™ Pedicle Screw System, Calix PC™ Titanium-Coated Intervertebral Fusion System, Fixcet™ Spinal Facet Screw System, Certex™ Spinal Fixation System, Calix™ PEEK-OPTIMA® Cervical and Lumbar Interbody Fusion Systems and the Butrex™ Anterior Plating System.

Company comments

“We are excited to expand our spinal treatment portfolio with the addition of the X-spine Axograft line of biologics. This launch exemplifies our continuing strategy to extend the X-spine footprint beyond our fixation products, and incorporate a broader view of the treatment of spine disease into biological and interventional arenas,” states X-spine’s CEO, Dr. David Kirschman.

Source: X-spine Systems, Inc., Business Wire

Share your thoughts

Your email address will not be published. Required fields are marked *